These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7624600)

  • 1. The effects of phenylephrine 2.5% versus phenylephrine 10% on pupillary dilation in patients with diabetes.
    Weiss JS; Weiss JN; Greenfield DS
    Retina; 1995; 15(2):130-3. PubMed ID: 7624600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects on pupil size and accommodation of sympathetic and parasympatholytic agents.
    Paggiarino DA; Brancato LJ; Newton RE
    Ann Ophthalmol; 1993 Jul; 25(7):244-9, 253. PubMed ID: 8363290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of 5% phenylephrine and 0.5% tropicamide eyedrops for pupil dilation in neonates is twice as effective as 0.5% tropicamide eyedrops alone.
    Lux AL; Degoumois A; Barjol A; Mouriaux F; Denion E
    Acta Ophthalmol; 2017 Mar; 95(2):165-169. PubMed ID: 27519933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose of 1% tropicamide and 10% phenylephrine for pupil dilation.
    Ratanapakorn T; Yospaiboon Y; Chaisrisawadsuk N
    J Med Assoc Thai; 2006 Nov; 89(11):1934-9. PubMed ID: 17205877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the Clinical Requirement of 2.5% Phenylephrine for Diagnostic Pupil Examination.
    Cho J; Bruck B; Liu JC; Culican SM
    J Ocul Pharmacol Ther; 2021 Jun; 37(5):284-289. PubMed ID: 33685234
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of an eye drop mixture for pupillary dilatation: A randomized comparative study.
    Bhurayanontachai P; Saengkaew S; Apiromruck P
    J Optom; 2017; 10(2):111-116. PubMed ID: 27321772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mydriatic drugs for diabetic patients.
    Huber MJ; Smith SA; Smith SE
    Br J Ophthalmol; 1985 Jun; 69(6):425-7. PubMed ID: 4039946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of commercial dilating agents on laser flare-cell measurements.
    Chin PK; Cuzzani OE; Gimbel HV; Sun R
    Can J Ophthalmol; 1996 Dec; 31(7):362-5. PubMed ID: 8971457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mydriatic and cardiovascular effects of phenylephrine 2.5% versus phenylephrine 10%, both associated with tropicamide 1%.
    Motta MM; Coblentz J; Fernandes BF; Burnier MN
    Ophthalmic Res; 2009; 42(2):87-9. PubMed ID: 19478547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparison of mydriatic effect between two drugs of different mechanism.
    Park JH; Lee YC; Lee SY
    Korean J Ophthalmol; 2009 Mar; 23(1):40-2. PubMed ID: 19337478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pupil dilation using phenylephrine alone or in combination with tropicamide.
    Eyeson-Annan ML; Hirst LW; Battistutta D; Green A
    Ophthalmology; 1998 Apr; 105(4):726-32. PubMed ID: 9544648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment.
    Marchini G; Babighian S; Tosi R; Perfetti S; Bonomi L
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):281-9. PubMed ID: 12506086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and in vivo evaluation of ocular insert containing phenylephrine and tropicamide.
    Lee YC; Millard J; Negvesky GJ; Butrus SI; Yalkowsky SH
    Int J Pharm; 1999 May; 182(1):121-6. PubMed ID: 10332081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular gelfoam disc-applicator for pupillary dilation in humans.
    Negvesky GJ; Butrus SI; Abifarah HA; Lee YC; Yalkowsky SH
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):311-5. PubMed ID: 10977126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination solution for routine pupillary dilation.
    Krumholz DM; Portello JK; Rosenfield M; Rosenbaum JD
    Optometry; 2006 Jul; 77(7):350-3. PubMed ID: 16814239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized double-blind study of phenylephrine 2.5% vs 10% on pupillary dilation.
    Yospaiboon Y; Luanratanakorn P; Noppawinyoowong C
    J Med Assoc Thai; 2004 Nov; 87(11):1380-4. PubMed ID: 15825717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and safety of the ophthalmic insert Mydriasert in patients undergoing retinal angiography.
    Cagini C; Caricato A; Tosi G; Pascale A; Cesari C; Fiore T
    Eur J Ophthalmol; 2014; 24(5):728-34. PubMed ID: 24557758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides.
    Chew C; Rahman RA; Shafie SM; Mohamad Z
    J Pediatr Ophthalmol Strabismus; 2005; 42(3):166-73. PubMed ID: 15977870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new preoperative ophthalmic solution.
    Hirowatari T; Tokuda K; Kamei Y; Miyazaki Y; Matsubara M
    Can J Ophthalmol; 2005 Feb; 40(1):58-62. PubMed ID: 15825531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Pupillary Dilation on Intraocular Pressure and Anterior Segment Morphology in Subjects with and without Pseudoexfoliation.
    Atalay E; Tamçelik N; Cicik ME
    Curr Eye Res; 2015 May; 40(6):646-52. PubMed ID: 25197765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.